Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice

Vaccine

Volumn 32, Issue 36, 2014, Pages 4672-4680

  Yu, Hong ^a   Karunakaran, Karuna P ^a   Jiang, Xiaozhou ^a   Brunham, Robert C ^a  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Chlamydia; Immunoproteomics; Recombinant protein; T cell antigens; Vaccine

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; OUTER MEMBRANE PROTEIN; PROTEIN PMPE; PROTEIN PMPF; PROTEIN PMPG; PROTEIN PMPH; RECOMBINANT POLYMORPHIC MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLAMYDIASIS; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; EVALUATION STUDY; FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C3H MOUSE; C57BL MOUSE; CHLAMYDIA; CHLAMYDIA INFECTIONS; DISEASE MODEL; IMMUNOLOGY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RECOMBINANT PROTEINS;

EID: 84924597333     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.002     Document Type: Article

References (45)

1. Starnbach M.N., Roan N.R. Conquering sexually transmitted diseases. Nat Rev Immunol 2008, 8:313-317.
2. Brunham R.C., Pourbohloul B., Mak S., White R., Rekart M.L. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005, 192:1836-1844.
3. Grayston J.T., Wang S.P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 1978, 5:73-77.
4. Wang S.P., Grayston J.T., Alexander E.R. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967, 63(Suppl.):1615-1630.
5. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005, 5:149-161.
6. Stanberry L.R., Rosenthal S.L. Progress in vaccines for sexually transmitted diseases. Infect Dis Clin North Am 2005, 19:477-490. xi.
7. Kari L., Whitmire W.M., Crane D.D., Reveneau N., Carlson J.H., Goheen M.M., et al. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol 2009, 182:8063-8070.
8. Pal S., Peterson E.M., de la Maza L.M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005, 73:8153-8160.
9. Pal S., Theodor I., Peterson E.M., de la Maza L.M. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Infect Immun 2001, 69:6240-6247.
10. Shaw J., Grund V., Durling L., Crane D., Caldwell H.D. Dendritic cells pulsed with a recombinant Chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun 2002, 70:1097-1105.
11. Pal S., Barnhart K.M., Wei Q., Abai A.M., Peterson E.M., de la Maza L.M. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 1999, 17:459-465.
12. Morrison R.P., Feilzer K., Tumas D.B. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995, 63:4661-4668.
13. Perry L.L., Feilzer K., Caldwell H.D. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 1997, 158:3344-3352.
14. Morrison S.G., Morrison R.P. A predominant role for antibody in acquired immunity to Chlamydial genital tract reinfection. J Immunol 2005, 175:7536-7542.
15. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282:754-759.
16. Read T.D., Brunham R.C., Shen C., Gill S.R., Heidelberg J.F., White O., et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000, 28:1397-1406.
17. Karunakaran K.P., Rey-Ladino J., Stoynov N., Berg K., Shen C., Jiang X., et al. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol 2008, 180:2459-2465.
18. Li L.X., McSorley S.J. B cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia muridarum genital tract infection. PLOS Pathog 2013, 9:e1003707.
19. Johnson R.M., Yu H., Kerr M.S., Slaven J.E., Karunakaran K.P., Brunham R.C. PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice. Infect Immun 2012, 80:2204-2211.
20. Yu H., Karunakaran K.P., Jiang X., Shen C., Andersen P., Brunham R.C. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice. Infect Immun 2012, 80:1510-1518.
21. Lu H., Xing Z., Brunham R.C. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. J Immunol 2002, 169:6324-6331.
22. Yang X., HayGlass K.T., Brunham R.C. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996, 156:4338-4344.
23. Yu H., Jiang X., Shen C., Karunakaran K.P., Brunham R.C. Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models. J Immunol 2009, 182:1602-1608.
24. Yu H., Jiang X., Shen C., Karunakaran K.P., Jiang J., Rosin N.L., et al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect Immun 2010, 78:2272-2282.
25. Liu S., Tobias R., McClure S., Styba G., Shi Q., Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 1997, 30:455-463.
26. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 2002, 76:9002-9010.
27. Yu H., Karunakaran K.P., Kelly I., Shen C., Jiang X., Foster L.J., et al. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol 2011, 186:3615-3621.
28. Johnson R.M., Kerr M.S., Slaven J.E. Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J Immunol 2012, 188:1896-1904.
29. Jayarapu K., Kerr M., Ofner S., Johnson R.M. Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms. J Immunol 2010, 185:6911-6920.
30. Molleken K., Schmidt E., Hegemann J.H. Members of the Pmp protein family of Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs. Mol Microbiol 2010, 78:1004-1017.
31. Molleken K., Becker E., Hegemann J.H. The Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entry. PLOS Pathog 2013, 9:e1003325.
32. Hansen J., Jensen K.T., Follmann F., Agger E.M., Theisen M., Andersen P. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital Chlamydial infection in a mouse model. J Infect Dis 2008, 198:758-767.
33. Andrew D.W., Hafner L.M., Beagley K.W., Timms P. Partial protection against Chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model. J Reprod Immunol 2011, 91:9-16.
34. Finco O., Frigimelica E., Buricchi F., Petracca R., Galli G., Faenzi E., et al. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc Natl Acad Sci U S A 2011, 108:9969-9974.
35. Baehr W., Zhang Y.X., Joseph T., Su H., Nano F.E., Everett K.D., et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A 1988, 85:4000-4004.
36. Ortiz L., Demick K.P., Petersen J.W., Polka M., Rudersdorf R.A., Van der Pol B., et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol 1996, 157:4554-4567.
37. Coler R.N., Bhatia A., Maisonneuve J.F., Probst P., Barth B., Ovendale P., et al. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis. FEMS Immunol Med Microbiol 2009, 55:258-270.
38. Jiang X., Shen C., Yu H., Karunakaran K.P., Brunham R.C. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology 2010, 129:556-566.
39. Belay T., Eko F.O., Ananaba G.A., Bowers S., Moore T., Lyn D., et al. Chemokine and chemokine receptor dynamics during genital Chlamydial infection. Infect Immun 2002, 70:844-850.
40. Pioli P.A., Amiel E., Schaefer T.M., Connolly J.E., Wira C.R., Guyre P.M. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004, 72:5799-5806.
41. Patton D.L., Kuo C.C. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fertil 1989, 85:647-656.
42. Shah A.A., Schripsema J.H., Imtiaz M.T., Sigar I.M., Kasimos J., Matos P.G., et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005, 32:49-56.
43. Darville T., O'Neill J.M., Andrews C.W., Nagarajan U.M., Stahl L., Ojcius D.M. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in Chlamydial genital tract infection. J Immunol 2003, 171:6187-6197.
44. Stephens R.S. The cellular paradigm of Chlamydial pathogenesis. Trends Microbiol 2003, 11:44-51.
45. Wolner-Hanssen P., Patton D.L., Holmes K.K. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991, 18:21-25.